1. Home
  2. SMX vs WVE Comparison

SMX vs WVE Comparison

Compare SMX & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SMX (Security Matters) Public Limited Company

SMX

SMX (Security Matters) Public Limited Company

HOLD

Current Price

$50.60

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$17.07

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMX
WVE
Founded
N/A
2012
Country
Ireland
Singapore
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SMX
WVE
Price
$50.60
$17.07
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$29.94
AVG Volume (30 Days)
1.4M
13.8M
Earning Date
04-23-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$109,230,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
103.75
52 Week Low
$3.12
$5.28
52 Week High
$66,187.38
$21.73

Technical Indicators

Market Signals
Indicator
SMX
WVE
Relative Strength Index (RSI) 42.32 61.91
Support Level $110.11 $15.23
Resistance Level $198.00 $18.50
Average True Range (ATR) 40.39 1.42
MACD -15.11 -0.10
Stochastic Oscillator 2.05 33.94

Price Performance

Historical Comparison
SMX
WVE

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: